Skip to Main Content

The gene-edited babies controversy got all the headlines, but there’s a lot more going on with the technology known as CRISPR these days.

Join STAT senior science writer Sharon Begley and senior biotech writer Adam Feuerstein for this CRISPR webinar. They’ll get you up to speed on the latest science, introduce you to some preclinical work that hints at diseases CRISPR might one day treat, and update you on ongoing human trials.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!